SY

Sharaf Yamani

Europe, England, United Kingdom, London

Description

Sharaf Yamani - Managing Director @ Windlesham Advisors

Investor Profile

Sharaf Yamani has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (100%)

Country Focus

  • United Kingdom (50%)
  • India (50%)

Industry Focus

  • Biotechnology
  • Industrial Automation
  • Life Science
  • Pharmaceutical
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sharaf Yamani frequently co-invest with?

A5
Europe, Hampshire, United Kingdom, Winchester
Co-Investments: 1
SOSV
North America, New Jersey, United States, Princeton
Co-Investments: 1
VH
Europe, England, United Kingdom, London
Co-Investments: 1

Which angels does Sharaf Yamani often collaborate with?

Shared Deals: 1
DR
Europe, England, United Kingdom, London
Shared Deals: 1
DL
Europe, England, United Kingdom
Shared Deals: 1
SM
Europe, United Kingdom
Shared Deals: 2
ME
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Sharaf Yamani?

CyGenica

Pune, Maharashtra, India

CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs and antibiotics.

Biotechnology
SeedJun 8, 2021
Amount Raised: $1,400,000
Synthace

London, England, United Kingdom

Synthace is a SaaS Life Sciences R&D Digital Experiment Platform.

BiotechnologyIndustrial AutomationLife SciencePharmaceuticalSoftware
SeedApr 12, 2013
Amount Raised: $900,000